within Pharmacolibrary.Drugs.C_CardiovascularSystem.C01B_AntiarrhythmicsClassIAndIii.C01BG11_Vernakalant;

model Vernakalant
  extends Pharmacolibrary.Drugs.ATC.C.C01BG11;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>C01BG11</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Vernakalant is an antiarrhythmic agent primarily used for the rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults. It acts as a multichannel blocker and is approved for intravenous use in Europe, Canada, and several other regions.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in adult patients with atrial fibrillation following intravenous administration.</p><h4>References</h4><ol><li><p>Finnin, M (2010). Vernakalant: A novel agent for the termination of atrial fibrillation. <i>American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists</i> 67(14) 1157–1164. DOI:<a href=&quot;https://doi.org/10.2146/ajhp080501&quot;>10.2146/ajhp080501</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/20592320/&quot;>https://pubmed.ncbi.nlm.nih.gov/20592320</a></p></li><li><p>Naccarelli, GV, et al., &amp; Gonzalez, MD (2008). Vernakalant--a promising therapy for conversion of recent-onset atrial fibrillation. <i>Expert opinion on investigational drugs</i> 17(5) 805–810. DOI:<a href=&quot;https://doi.org/10.1517/13543784.17.5.805&quot;>10.1517/13543784.17.5.805</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18447605/&quot;>https://pubmed.ncbi.nlm.nih.gov/18447605</a></p></li><li><p> (2007). Vernakalant: RSD 1235, RSD-1235, RSD1235. <i>Drugs in R&amp;D</i> 8(4) 259–265. DOI:<a href=&quot;https://doi.org/10.2165/00126839-200708040-00007&quot;>10.2165/00126839-200708040-00007</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17596113/&quot;>https://pubmed.ncbi.nlm.nih.gov/17596113</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Vernakalant;
